Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis

Medicine

Volumn 88, Issue 4, 2009, Pages 227-235

  Gonzalez Gay, Miguel A ^a   Vazquez Rodriguez, Tomas R ^a   Gomez Acebo, Ines ^c   Pego Reigosa, Robustiano ^a   Lopez Diaz, Maria J ^a   Vazquez Triñanes, Matilde C ^a   Miranda Filloy, Jose A ^a   Blanco, Ricardo ^a,b   Dierssen, Trinidad ^c   Gonzalez Juanatey, Carlos ^a   Llorca, Javier ^c,d  

^a HOSPITAL XERAL CALDE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE; CORTICOSTEROID;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; ASTHENIA; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FEMALE; GIANT CELL ARTERITIS; HUMAN; HYPERTENSION; INCIDENCE; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; STROKE; TEMPORAL ARTERY; VERTEBRAL ARTERY; VISUAL IMPAIRMENT; WEIGHT REDUCTION; BIOPSY; BLINDNESS; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADRENAL CORTEX HORMONES; AGED; ANEMIA; BIOPSY; BLINDNESS; FEMALE; GIANT CELL ARTERITIS; HUMANS; HYPERTENSION; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TEMPORAL ARTERIES;

EID: 67651091666     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181af4518     Document Type: Article

References (45)

1. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
2. Alzamora MT, Sorribes M, Heras A, Vila N, Vicheto M, Fores R, Sanchez-Ojanguren J, Sancho A; "ISISCOG Study Group," Pera G. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol. 2008;8:5.
3. Bengtsson B.-A. Haematological observations in giant cell arteritis. Acta Med Scand. 1982;(Suppl)658:38-43.
4. Berger CT, Wolbers M, Meyer P, Daikeler T, Hess C. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford). 2009;48:258-261.
5. Caselli RJ, Daube JR, Hunder GG, Whisnant JP Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology. 1988;38:352-359.
6. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am. 1993;19:941-953.
7. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, Vilaseca J, Urbano-Marquez A, Grau JM. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998;41:26-32.
8. Cid MC, Hernandez-Rodriguez J, Esteban MJ, Cebrian M, Gho YS, Font C, Urbano-Marquez A, Grau JM, Kleinman HK. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation. 2002;106:1664-1671.
9. Conn DL, Tompkins RB, Nichols WL. Glucocorticoids in the management of vasculitis - a double edged sword? J Rheumatol. 1988;15:1181-1183.
10. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33:289-293.
11. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol. 1992;19:277-280.
12. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33:38-48.
13. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84:269-276.
14. Gonzalez-Gay MA, Blanco R, Abraira V Garcia-Porrua C, Ibanez D, Garcia-Pais MJ, Rigueiro MT, Sanchez-Andrade A, Guerrero J, Casariego E. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol. 1997;24:2171-2176.
15. Erratum in: J Rheumatol. 1998;25:193.
16. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Unarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998;41:1497-1504.
17. Gonzalez-Gay MA, Boiardi L, Garcia-Porrua C, Macchioni P, Amor-Dorado JC, Salvarani C. Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern Europe. J Rheumatol. 2004;31:520-523.
18. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiological aspects. Medicine (Baltimore). 1999;78:292-308.
19. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27:729-749.
20. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum. 2001;30:249-256.
21. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, Gonzalez-Louzao C, Rodriguez-Gil E, Rodriguez-Ledo P, Ollier WE. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283-292.
22. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore). 2004;83:335-341.
23. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol. 1998;25:1750-1755.
24. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a ten-year study. J Rheumatol. 1999;26:1326-1332.
25. Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore). 2005;84:277-290.
26. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore). 2007;86:61-68.
27. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, Llorca J. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83:342-347.
28. Gonzalez-Gay MA, Vazquez-Rodriguez T, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. The epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009 (in press).
29. Gonzalez-Juanatey C, Lopez-Diaz MJ, Martin J, Llorca J, Gonzalez-Gay MA. Atherosclerosis in patients with biopsy-proven giant cell arteritis. Arthritis Rheum. 2007;57:1481-1486.
30. Graham E, Holland A, Avery A, Russell RW Prognosis in giant-cell arteritis. Br Med J. 1981;282:269-271.
31. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford). 2001;40:1238-1242.
32. Hellmann DB. Temporal arteritis: a cough, toothache, and tongue infarction. JAMA. 2002;287:2996-3000.
33. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
34. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol. 2002;14:3-10.
35. Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Pena-Sagredo JL, Martin J, Gonzalez-Gay MA. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum. 2008;38:116-123.
36. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100:193-196.
37. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50:1332-1337.
38. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ. 1989;299:549-550.
39. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-3531.
40. Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzalez-Gay MA. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S13-17.
41. Reich KA, Giansiracusa DF, Strongwater SL. Neurologic manifestations of giant cell arteritis. Am J Med. 1990;89:67-72.
42. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol. 2005;32:1737-1741.
43. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
44. Salvarani C, Delia Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiardi L. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford). 2009;48:250-253.
45. Turney TM, Garraway WM, Whisnant JP The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke. 1984;15:790-794.